A 30-month Follow-up of MERINO Participants to Evaluate Long-term Effects of Methotrexate in Erosive Hand OA.

Enrolling by invitationOBSERVATIONAL

Enrollment

108

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions

Hand OsteoarthritisErosive Osteoarthritis

Interventions

DRUG

Methotrexate

Methotrexate 5-25 mg x 1 per week, combined with folic acid 1mg daily.

OTHER

Treatment as usual

No specific treatment after MERINO-trial

Trial Locations (1)

Diakonhjemmet Hospital, Oslo

All Listed Sponsors

lead

Diakonhjemmet Hospital

OTHER